Showing results for "Category/Adult/Blood Disorders"

Found 7 Clinical Trial s

ACTIV-4C - Post-hospital

The purpose of the study is to determine the most most effective and safe to prevent blood clots.


The purpose of this study is to understand why strokes happen in sickle cell disease.


The purpose of the study is to look at the effectiveness of lanadelumab in preventing HAE (Hereditary Angioedema) attacks . It will also examine the quality of life and the use of healthcare resources for HAE attacks before and after lanadelumab treatment.


The purpose of the study is to examine whether sleep duration affects blood sugar control.

P2 BMT vs. SOC in SCD (CTN1503)

The purpose of this clinical trial is to find out if bone marrow transplantation is better than standard of care in improving survival and decreasing sickle cell-related complications for young adults with severe sickle cell disease (SCD).

Lanadelumab in normal C1

The purpose of the research study is to test a drug (Lanadelumab) in people with Hereditary Angioedema (HAE) who have normal C1 but still experience angioedema and are not responsive to antihistamines.

The C-TRACT Trial

This study is examining new treatments for vein damage caused by blood clots (DVT).